Stefan Oelrich

Stefan Oelrich is the head of Bayer's pharmaceutical division, where he is known for overseeing the development of significant new treatments, including Nubeqa, a drug for prostate cancer that has been described as potentially the largest product the company has ever produced. Under his leadership, Bayer is working on innovative solutions and strategies to enhance efficiency within the company.